Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Australian shares have rebounded impressively since April, but the real test will be the upcoming earnings season.

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Medpace stock soared after quarterly earnings beat expectations. If gains hold, that’d be the clinical research company's largest single-day increase on record.

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience long periods of nothing much happening, interrupted by periods of sharp ...

And even after the significant gains it has experienced in recent years, it might still be early enough to get on the ...

Unless a significant macroeconomic shock occurs, Bitcoin's mid-term prospects remain constructive, with the potential to ...